tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of John Newman, 210 are a BUY (89.74%), 24 are a HOLD (10.26%).
Analyst John Newman, currently employed at CANACCORD, carries an average stock price target met ratio of 35.11% that have a potential upside of 23.95% achieved within 160 days.
John Newman’s has documented 431 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Financial Services, Industrials, Communication Services, Energy, Basic Materials sectors.
Most recent stock forecast was given on BNTX, BioNTech SE at 31-Aug-2026.
Analyst best performing recommendations are on TSVT (2SEVENTY BIO).
The best stock recommendation documented was for ACLX (ARCELLX) at 4/19/2023. The price target of $40 was fulfilled within 5 days with a profit of $4.74 (13.44%) receiving and performance score of 26.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 05-Jan-2024
$37
$5.19 (16.32%)
$39
Buy Since 31-Mar-2026
$50
$18.19 (57.18%)
$46
22 days ago
(21-Sep-2026)
3/5 (60%)
$16.05 (47.28%)
72
Hold Since 01-Dec-2022
$34
$2.19 (6.88%)
$31
2 months 6 days ago
(07-Aug-2026)
11/12 (91.67%)
$1.73 (5.36%)
113
Buy Since 05-Mar-2026
$52
$20.19 (63.47%)
$46
2 months 12 days ago
(31-Jul-2026)
1/3 (33.33%)
$21.98 (73.22%)
215
Buy Since 24-Feb-2025
$55
$23.19 (72.90%)
$52
2 months 13 days ago
(30-Jul-2026)
0/11 (0%)
$22.25 (67.94%)
Which stock is John Newman most bullish on?
Which stock is John Newman most reserved on?
What Year was the first public recommendation made by John Newman?
